Stem cell biotech MoglinBio secures seed investment
KIZOO Technology Ventures - 26-Oct-2022Kizoo is focused on rejuvenation biotech so it must see potential in normalizing CDC42 activity
Join the club for FREE to access the whole archive and other member benefits.
Director of Experimental Hematology and Cancer Biology, Co-Director at Cancer and Blood Diseases Institute
The research activities of Dr. Yi Zheng’s laboratory focus on studies of the physiological and pathological function and the mechanism of regulation of Rho family GTP-binding proteins.
The Rho GTPases are a class of intracellular signal transducers that play important roles in the regulation of diverse cellular activities including actin cytoskeleton reorganization, transcription activation, and DNA synthesis. Like Ras, mutation, overexpression or disruption of the normal mode of regulation of these GTP-binding and GTP-hydrolyzing molecular switches may lead to cellular transformation, morphological changes, and developmental disorders.
Co-founder of Mogling Bio.
Visit website: https://www.cincinnatichildrens.org/research/divisions/e/ex-hem/labs/zheng
See also: Cincinnati Children’s Hospital Medical Center - Academic pediatric acute care children's hospital
Details last updated 28-Oct-2022
Kizoo is focused on rejuvenation biotech so it must see potential in normalizing CDC42 activity